{
  "uuid": "",
  "id": "Mayo_Alliance_Prognostic_System_MAPS_Score.v0-draft",
  "gdl_version": "2.1",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "name": "Katja Mariko Wilde",
      "email": "katja-wilde@t-online.de",
      "organisation": "Cambio CDS",
      "date": "2025-09-11"
    },
    "lifecycle_state": "DRAFTED",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To record the results for each component parameter and their total sum for the MAPS score.",
        "keywords": [
          "MAPS",
          "Mayo",
          "alliance",
          "prognostic",
          "system",
          "score",
          "systemic mastocytosis",
          "age",
          "platelets",
          "serum alp",
          "mutations"
        ],
        "use": "Use to record the results for each component parameter and their total sum for the MAPS score.",
        "misuse": "Not to be used for recording information related to other prognostic models for systemic mastocytosis.",
        "copyright": "Â© Cambio CDS"
      }
    },
    "other_details": {
      "references": "Pardanani A, Shah S, Mannelli F, Elala YC, Guglielmelli P, Lasho TL, Patnaik MM, Gangat N, Ketterling RP, Reichard KK, Hanson CA, Vannucchi AM, Tefferi A. Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models. Blood Adv. 2018 Nov 13;2(21):2964-2972. doi: 10.1182/bloodadvances.2018026245. PMID: 30413432; PMCID: PMC6234360.",
      "en": "MAPS Score"
    }
  },
  "definition": {},
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Mayo Alliance Prognostic System (MAPS) Score",
            "description": "An assessment score used at the bedside to risk stratify adult patients with systemic mastocytosis (SM)."
          }
        }
      }
    }
  }
}